Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
 
Join | Sign in
Home>News

  News Archive

Evotec raises € 30 m from Biotechnology Value Fund
Monday, September 02, 2013
Biotechnology Value Fund, L.P. and other affiliates of US investment firm BVF partners L.P. (“BVF”) invest € 30 M in new Evotec shares.

Endocannabinoids Trigger Inflammation That Leads to Diabetes
Thursday, August 22, 2013
NIH scientists identify possible treatment target for type 2 diabetes.

Dogs Could Act as Effective Early-Warning System for Patients with Diabetes
Wednesday, August 21, 2013
Dogs that are trained to respond to their owners’ hypoglycaemia could offer a very effective way to alert diabetic patients of impending lowered blood sugars.

Possible Treatment Target for Type 2 Diabetes Identified
Tuesday, August 20, 2013
Researchers at the NIH have clarified in rodent and test tube experiments the role that inflammation plays in type 2 diabetes, revealing a possible molecular target for treating the disease.

Agilent Recognized as 2013 Laboratory Analytical Instrumentation Company of the Year in China
Tuesday, August 20, 2013
The company ranked highest in industry for leadership, growth, innovation and customer service by Frost & Sullivan.

Sanford-Burnham to Partner with Pfizer
Tuesday, August 20, 2013
The collaboration will see the organisations identify new therapeutic targets for preventing and treating complications of obesity and diabetes.

Agilent Reports Third-Quarter Results
Thursday, August 15, 2013
Revenues were $1.65 billion for the third fiscal quarter ended July 31, 2013, down 4 percent over one year ago.

Cenix BioScience Joins EU FP7 Consortium for Discovery of miRNA Medicines
Wednesday, August 14, 2013
Company has joined an EU-funded consortium focused on the discovery of microRNA medicines in the area of cardiac and inflammatory metabolic diseases.

Effect of Trans Fatty Acid Intake on LC-MS and NMR Plasma Profiles
Tuesday, August 13, 2013
In this study, NMR and LC-MS untargeted metabolomics has been used as an approach to explore the impact of trans fatty acid intake on plasma metabolites.

<< 13 14 15 16 17 18 19 >>
Showing Results 151 - 160 of 1425
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters